ArticleMedical journal, Armed Forces India
Neutrophil-lymphocyte ratio as an early predictive biomarker for severity in patients with high altitude pulmonary edema.
Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High altitude pulmonary edema (HAPE) is a serious condition characterized by pulmonary edema occurring at high altitudes, posing a medical emergency. Biomarkers predicting HAPE severity remain elusive, prompting the exploration of accessible indicators such as Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-toLymphocyte Ratio (PLR). This study aimed to assess the predictive role of NLR and PLR in HAPE severity, alongside analyzing its clinical profile and outcomes. Methods: A single-center cross-sectional comparative study was conducted in a high-altitude hospital in North Sikkim. Participants underwent acclimatization at varying altitudes, with medical history and examinations recorded. HAPE severity was categorized based on symptoms, pulse, respiratory rate, and chest radiograph findings. NLR and PLR were calculated, and their association with severity, hospitalization duration, and oxygen support days were analyzed. Statistical methods included logistic regression, Receiver Operating Characteristic (ROC) curve analysis, and cutoff determination. Results: Dyspnea and cough showed significant correlation with HAPE severity. Tachycardia, tachypnea, and adventitious sounds during auscultation were significantly associated with severity. Hematological parameters revealed higher NLR and PLR in severe cases, with NLR demonstrating sensitivity and specificity in distinguishing severe from non-severe cases. Conclusion: A comprehensive assessment involving clinical symptoms and hematological parameters aids in determining HAPE severity. NLR emerges as a promising, costeffective marker for severity prediction. Further research with larger cohorts and multicenter studies is needed to validate these findings and establish optimal cutoff values. Nevertheless, this study underscores the importance of accessible biomarkers in HAPE, particularly in resource-limited settings, offering valuable insights into disease severity assessment and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.